LifeStance price target raised to $8 from $7 at Barclays

Barclays raised the firm’s price target on LifeStance to $8 from $7 and keeps an Underweight rating on the shares post the Q4 report. The analyst believes LifeStance remains in the early days of its margin expansion opportunity but says the stock’s valuation is “already rich.”